The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Changes in Insulin Sensitivity and Insulin Release in Relation to Glycemia and Glucose Tolerance in 6,414 Finnish Men
Open accessAbstract
OBJECTIVE: We evaluated insulin sensitivity and insulin secretion across the entire range of fasting (FPG) and 2-h plasma glucose (PG), and we investigated the differences in insulin sensitivity and insulin release in different glucose tolerance categories. RESEARCH DESIGN AND METHODS: A total of 6,414 Finnish men (aged 57 ± 7 years, BMI 27.0 ± 3.9 kg/m2) from our ongoing population-based METSIM (Metabolic Syndrome in Men) study were included. Of these subjects, 2,168 had normal glucose tolerance, 2,859 isolated impaired fasting glucose (IFG), 217 isolated impaired glucose tolerance (IGT), 701 a combination of IFG and IGT, and 469 newly diagnosed type 2 diabetes. RESULTS: The Matsuda index of insulin sensitivity decreased substantially within the normal range of FPG (−17%) and 2-h PG (−37%) and was approximately −65 and −53% in the diabetic range of FPG and 2-h PG, respectively, compared with the reference range (FPG and 2-h PG <5.0 mmol/l). Early-phase insulin release declined by only approximately −5% within the normal range of FPG and 2-h PG but decreased significantly in the diabetic range of FPG (by 32–70%) and 2-h PG (by 33–51%). Changes in insulin sensitivity and insulin secretion in relation to hyperglycemia were independent of obesity. The predominant feature of isolated IGT was impaired peripheral insulin sensitivity. Isolated IFG was characterized by impaired early and total insulin release. CONCLUSIONS: Peripheral insulin sensitivity was already decreased substantially at low PG levels within the normoglycemic range, whereas impairment in insulin secretion was observed mainly in the diabetic range of FPG and 2-h PG. Obesity did not affect changes in insulin sensitivity or insulin secretion in relation to hyperglycemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Insulin resistance is already well established when impaired glucose tolerance is present”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [9]
In the citing paper
“the increase in glucose, even across the normal range, is due to a continuous decline in β-cell function9.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.
Stumvoll, M., Mitrakou, A., Pimenta, W., Jenssen, T., Yki-Järvinen, H., Van Haeften, T., Renn, W., & Gerich, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.295 · Cited by 1,042
The Rising Prevalence of Diabetes and Impaired Glucose Tolerance
Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., de Courten, M. P., Cameron, A. J., Sicree, R. A., Dwyer, T., Colagiuri, S., Jolley, D., Knuiman, M., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.5.829 · Cited by 907
Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts
The DECODE Study Group (2003) · Diabetes Care · doi:10.2337/diacare.26.1.61 · Cited by 608
Genome–wide association studies provide new insights into type 2 diabetes aetiology
Frayling, T. M. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2178 · Cited by 594
Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
Cited by
Integrative approaches for large-scale transcriptome-wide association studies
Gusev, A., Ko, A., Shi, H., Bhatia, G., Chung, W., Penninx, B. W. J. H., Jansen, R., de Geus, E. J. C., Boomsma, D. I., Wright, F. A., et al. (2016) · Nature Genetics · doi:10.1038/ng.3506 · Cited by 2,479
Self-citationPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Poznyak, A., Grechko, A. V., Poggio, P., Myasoedova, V. A., Alfieri, V., & Orekhov, A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051835 · Cited by 1,163
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Insulin resistance and hyperglycaemia in cardiovascular disease development
Laakso, M., & Kuusisto, J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.29 · Cited by 858
Self-citationHirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787
“To further investigate the correlation between rs11246020 and the metabolic syndrome in humans, we evaluated rs11246020 in the Metabolic Syndrome in Men (METSIM) cohort containing approximately 8000 Finnish men (Stancáková et al., 2009).”
InfluentialSelf-citationNon-coding genetic variants in human disease: Figure 1.
Zhang, F., & Lupski, J. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv259 · Cited by 609
Udler, M. S., Kim, J., von Grotthuss, M., Bonàs-Guarch, S., Cole, J. B., Chiou, J., ISGC, C. D. A. O. B. O. M. A. T., Boehnke, M., Laakso, M., Atzmon, G., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002654 · Cited by 542
Self-citationBranched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults
Würtz, P., Soininen, P., Kangas, A. J., Rönnemaa, T., Lehtimäki, T., Kähönen, M., Viikari, J. S., Raitakari, O. T., & Ala-Korpela, M. (2013) · Diabetes Care · doi:10.2337/dc12-0895 · Cited by 548
Voight, B. F., Kang, H. M., Ding, J., Palmer, C. D., Sidore, C., Chines, P. S., Burtt, N. P., Fuchsberger, C., Li, Y., Erdmann, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002793 · Cited by 472
Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A., & Smith, U. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2017 · Cited by 462
de Mello, V. D., Paananen, J., Lindström, J., Lankinen, M. A., Shi, L., Kuusisto, J., Pihlajamäki, J., Auriola, S., Lehtonen, M., Rolandsson, O., et al. (2017) · Scientific Reports · doi:10.1038/srep46337 · Cited by 379
Self-citationOrg, E., Blum, Y., Kasela, S., Mehrabian, M., Kuusisto, J., Kangas, A. J., Soininen, P., Wang, Z., Ala-Korpela, M., Hazen, S. L., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1194-2 · Cited by 331
Self-citationCederberg, H., Stančáková, A., Yaluri, N., Modi, S., Kuusisto, J., & Laakso, M. (2015) · Diabetologia · doi:10.1007/s00125-015-3528-5 · Cited by 316
Self-citationHuyghe, J. R., Jackson, A. U., Fogarty, M. P., Buchkovich, M. L., Stančáková, A., Stringham, H. M., Sim, X., Yang, L., Fuchsberger, C., Cederberg, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2507 · Cited by 282
Self-citationStančáková, A., Civelek, M., Saleem, N. K., Soininen, P., Kangas, A. J., Cederberg, H., Paananen, J., Pihlajamäki, J., Bonnycastle, L. L., Morken, M. A., et al. (2012) · Diabetes · doi:10.2337/db11-1378 · Cited by 279
Self-citationMancuso, N., Shi, H., Goddard, P., Kichaev, G., Gusev, A., & Pasaniuc, B. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.031 · Cited by 273
Uusitupa, M., Hermansen, K., Savolainen, M. J., Schwab, U., Kolehmainen, M., Brader, L., Mortensen, L. S., Cloetens, L., Johansson‐Persson, A., Önning, G., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12044 · Cited by 264
Phenotypes of prediabetes and stratification of cardiometabolic risk
Stefan, N., Fritsche, A., Schick, F., & Häring, H.-U. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)00082-6 · Cited by 208
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180
“In a follow-up study of 8000 Finnish men focusing specifically on rs11246020, we sought to validate this SNP association with the metabolic syndrome (Stancáková et al. 2009).”
BackgroundIncreased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients
Hu, H., Sun, W., Yu, S., Hong, X., Qian, W., Tang, B., Wang, D., Yang, L., Wang, J., Mao, C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0602 · Cited by 171
Meijnikman, A. S., De Block, C. E. M., Dirinck, E., Verrijken, A., Mertens, I., Corthouts, B., & Van Gaal, L. F. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.165 · Cited by 112
Lorenzo, C., Haffner, S. M., Stančáková, A., & Laakso, M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1144 · Cited by 92
Self-citationHsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91
“Both IFG and IGT are associated with impairment of insulin secretion.(44) Individuals”
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits
Civelek, M., Hagopian, R., Pan, C., Che, N., Yang, W.-P., Kayne, P. S., Saleem, N. K., Cederberg, H., Kuusisto, J., Gargalovic, P. S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt159 · Cited by 89
Self-citationStatins and risk of type 2 diabetes: mechanism and clinical implications
Laakso, M., & Fernandes Silva, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1239335 · Cited by 82
Self-citationDecreased plasma β‐amyloid in the Alzheimer's disease APP A 673 Tvariant carriers
Martiskainen, H., Herukka, S., Stančáková, A., Paananen, J., Soininen, H., Kuusisto, J., Laakso, M., & Hiltunen, M. (2017) · Annals of Neurology · doi:10.1002/ana.24969 · Cited by 64
“The study design has been described in detail earlier.(9) A total of 37 METSIM participants among the 4,916 genotyped individuals were heterozygous carriers of the C-allele of ABCA7 rs200538373 splice site variant leading to a premature stop codon and thus loss of function (c.”
MethodSelf-citationTfayli, H., Lee, S., & Arslanian, S. (2010) · Diabetes Care · doi:10.2337/dc09-2292 · Cited by 57
“2 mg/dl compared with that for FPG 90 mg/dl independent of obesity (13).”
BackgroundVangipurapu, J., Stančáková, A., Kuulasmaa, T., Kuusisto, J., & Laakso, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124028 · Cited by 46
“Evaluation of insulin secretion (InsAUC0-30/GlucAUC0-30) and insulin sensitivity (Matsuda ISI) have been previously described [18,21].”
MethodSelf-citationHeikkilä, H. M., Krachler, B., Rauramaa, R., & Schwab, U. S. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514002426 · Cited by 12
“an index of total insulin secretion during the OGTT; calculated as a quotient of insulin AUC and glucose AUC between the time points 0 and 120 min of OGTT, where the trapezoidal method was used for the calculation of the entire AUC (not incremental AUC); units used in the calculation were as follows: glucose (mmol/l)…”
Influential
Metadata
- Authors
- Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M.
- Affiliations
- Kuopio University Hospital (FI)
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Laakso, Markku
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-02-17
- Volume
- 58
- Issue
- 5
- Pages
- 1212-1221
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2671053
- OpenAlex
- W2108628281
- Cited by
- 348
- References
- 47
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 19 · 2023: 21 · 2022: 21 · 2021: 21 · 2020: 22 · 2019: 20 · 2018: 21 · 2017: 36 · 2016: 19 · 2015: 26 · 2014: 23 · 2013: 18 · 2012: 16
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Academy of Finland (124243)
- Tekes (1510/31/06)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- insulin sensitivity, insulin secretion, glucose tolerance, impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, Matsuda index, hyperglycemia, obesity, men
- MeSH terms
- Insulin Secretion, Blood Glucose, Cross-Sectional Studies, Finland, Glucose Tolerance Test, Humans, Insulin, Male, Middle Aged, Reference Values, Glucose Intolerance, Area Under Curve, Metabolic Syndrome, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.